Treatment with insulin or oral antidiabetic drugs wasmentioned only by Buchner et al.8 Regarding SAH and dyslipidemia, Gottlieb et al.6 reported only the number ofpatients on antihypertensives or lipid-lowering drugs, and Marin etal.7 registered onlythe total number of SAH and dyslipidemia patients. This evidence concerns the gene INS and metabolic syndrome.